Advanced Forum on

Biotech Patents

The Tactical and Practical Guide to Today's Most Complex Issues

Wednesday, October 08, 2003

About

The human genome has been mapped and patented. Science now stands on the threshold of deciphering the mysteries of the proteins that manipulate and control gene function. As new and amazing genomic and proteomic discoveries continue to be made, biotech and pharmaceutical companies are seeking to patent the tools and processes which have allowed them and continue to allow them to unlock the secrets of genetic defects and disease in their quest to develop new drugs and therapies. Moreover, based on the number of infringement actions filed this year alone, they are clearly holding no bars to protect the biotech inventions on which they already hold patents.

With millions in future revenue at stake, it is imperative that counsel to biotech and pharmaceutical companies and their advisors have an up-to the minute and complete understanding of the latest legal developments affecting biotech patents. These American Conference Institute conference materials will bring you thoughtful and targeted commentary and in-depth analysis from an outstanding faculty of leading in-house biotech and pharmaceutical counsel and expert attorneys. They will provide practical, comprehensive information and insights on:

  • Significant case law and actions to watch
  • How pending reforms for pharmaceutical patents may affect biotech patents
  • Strategies for patenting and defending reach-through claims
  • Understanding and mastering the Written Description Guidelines
  • How to draft claims broad enough and specific enough to adequately protect your biotech related inventions
  • The impact of the new standards for utility and enablement on patenting gene and protein function and genomic and proteomic sequences
  • Successful licensing: tips and traps in view of recent developments
  • How to conduct a freedom to operate analysis in the evolving biotech patent landscape
In addition, a highlight of this program will be a special Focus on Research Tool/Method Patents: An Examination of Infringement, Defenses, Remedies and Preventative Measures in Light of Recent Decisions. These special focus sessions shed light on recent decisions regarding infringement of research tools/method patents and provide you with tips for avoiding infringement while protecting and developing your own biotech and related inventions.

This is by far the most comprehensive program of the year on biotech patents. Take this opportunity to get the information that you need from those on the leading edge of law and science.

Contents & Contributors

About

The human genome has been mapped and patented. Science now stands on the threshold of deciphering the mysteries of the proteins that manipulate and control gene function. As new and amazing genomic and proteomic discoveries continue to be made, biotech and pharmaceutical companies are seeking to patent the tools and processes which have allowed them and continue to allow them to unlock the secrets of genetic defects and disease in their quest to develop new drugs and therapies. Moreover, based on the number of infringement actions filed this year alone, they are clearly holding no bars to protect the biotech inventions on which they already hold patents.

With millions in future revenue at stake, it is imperative that counsel to biotech and pharmaceutical companies and their advisors have an up-to the minute and complete understanding of the latest legal developments affecting biotech patents. These American Conference Institute conference materials will bring you thoughtful and targeted commentary and in-depth analysis from an outstanding faculty of leading in-house biotech and pharmaceutical counsel and expert attorneys. They will provide practical, comprehensive information and insights on:

  • Significant case law and actions to watch
  • How pending reforms for pharmaceutical patents may affect biotech patents
  • Strategies for patenting and defending reach-through claims
  • Understanding and mastering the Written Description Guidelines
  • How to draft claims broad enough and specific enough to adequately protect your biotech related inventions
  • The impact of the new standards for utility and enablement on patenting gene and protein function and genomic and proteomic sequences
  • Successful licensing: tips and traps in view of recent developments
  • How to conduct a freedom to operate analysis in the evolving biotech patent landscape
In addition, a highlight of this program will be a special Focus on Research Tool/Method Patents: An Examination of Infringement, Defenses, Remedies and Preventative Measures in Light of Recent Decisions. These special focus sessions shed light on recent decisions regarding infringement of research tools/method patents and provide you with tips for avoiding infringement while protecting and developing your own biotech and related inventions.

This is by far the most comprehensive program of the year on biotech patents. Take this opportunity to get the information that you need from those on the leading edge of law and science.

Contents & Contributors

The Contents and Contributors description for this publication is not available at this time.


DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0